ArticleFrontiers in oncology2026

Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.

Mitsuaki Oura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.